Forbes September 24, 2021
Covid-19 test maker Cue Health went public on Friday at a valuation of nearly $2.3 billion. Shares opened above the $16 price set the night before and closed at $20—a 25% increase in the first day of trading. The San Diego, California-based company’s Covid-19 test—which consists of a swab, test cartridge and battery-operated reusable reader about the size of a smartphone—delivers test results in around 20 minutes and automatically uploads them to a mobile app. It’s used by a wide array of customers, including the Mayo Clinic, the Pentagon and even the Iditarod race in Alaska.
“The company is very mission driven. We want to make healthcare information more accessible,” says cofounder and CEO, Ayub Khattak. Access to Covid-19 tests...
Today's Sponsors
Today's Sponsor